Investigating the role of TDP-43 protein in age-related dementias
Biochemical and molecular heterogeneity of human TDP-43 proteinopathies in age-related dementias
This study is looking at how a protein called TDP-43 affects the brains of older adults with different types of dementia, like Alzheimer's, to help find better ways to diagnose and treat these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11076248 on NIH RePORTER |
What this research studies
This research focuses on understanding the biochemical and molecular differences in TDP-43 proteinopathies, which are linked to various forms of dementia, particularly in older adults. By examining brain samples from individuals with Alzheimer's disease and other dementias, the study aims to identify how TDP-43 pathology contributes to cognitive decline. The approach includes analyzing the presence and distribution of TDP-43 deposits in the brain, as well as exploring genetic and neuroimaging features associated with these conditions. This research could lead to better diagnostic and therapeutic strategies for age-related dementias.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing cognitive decline or diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with early-onset dementia or those without cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could improve the understanding and treatment of dementias associated with aging, potentially leading to better patient outcomes.
How similar studies have performed: Previous studies have shown promising results in understanding TDP-43 proteinopathies, indicating that this research builds on established findings in the field.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Porta Antolinez, Silvia — University of Pennsylvania
- Study coordinator: Porta Antolinez, Silvia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.